Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
Clinical trial NCT07226531 · COMPLETED
Trial details
- NCT number
- NCT07226531
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-22
- Primary completion
- 2026-03-06
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.